MAGE-1 (90-104)

MAGE-1 (90-104) is a synthetic peptide segment derived from the melanoma-associated antigen 1 (MAGE-1) protein, specifically encompassing amino acids 90 to 104 of the full-length sequence. As a member of the cancer-testis antigen family, MAGE-1 is recognized for its restricted expression in various tumor types and its immunogenic properties, making it a prominent focus in tumor immunology and antigen-specific research. The 90-104 peptide fragment represents an epitope of interest for studying cellular immune responses, T-cell activation, and antigen processing pathways. Its defined sequence enables reproducible results across immunological assays, supporting advanced investigations into tumor antigenicity, peptide-MHC binding, and the development of novel immunological tools.

Epitope mapping: Researchers utilize the 90-104 peptide to map T-cell epitopes within the MAGE-1 protein, facilitating the identification of immunodominant regions that are recognized by cytotoxic T lymphocytes. By employing this defined sequence in in vitro stimulation assays or peptide-MHC tetramer studies, investigators can dissect the specificity and magnitude of immune responses directed against tumor-associated antigens. This approach enables a deeper understanding of antigenic determinants critical for immune recognition and informs the design of antigen-targeted immunological studies.

Antigen presentation studies: The peptide serves as a valuable substrate for examining the mechanisms of antigen processing and presentation. By introducing the MAGE-1 (90-104) fragment into antigen-presenting cells, scientists can analyze its binding affinity to various major histocompatibility complex (MHC) class I or II molecules, as well as the subsequent activation of T-cell subsets. These studies are essential for elucidating the pathways by which tumor antigens are displayed to the immune system and for optimizing peptide selection in immunological model systems.

T-cell activation assays: The defined structure of the 90-104 peptide allows for precise evaluation of T-cell responses in both primary and engineered immune cell populations. In functional assays, the peptide is employed to stimulate antigen-specific T-cells, enabling measurement of cytokine production, proliferation, or cytotoxic activity. These experiments provide insights into the immunogenic potential of the epitope and support the validation of T-cell receptor specificity, which is critical for immunotherapy research and adoptive cell transfer studies.

Immunological reagent development: The peptide fragment is frequently incorporated into the design of immunological reagents, such as peptide-MHC multimers or synthetic vaccine constructs. Its well-defined sequence and immunogenicity make it suitable for generating reference reagents used in flow cytometry, ELISPOT, or other immune monitoring platforms. Such reagents facilitate the detection and quantification of antigen-specific T-cells in research samples, supporting the standardization of immune assays and the advancement of translational immunology.

Peptide-based assay validation: Laboratories employ the 90-104 sequence as a positive control or reference standard in the development and validation of peptide-based immunoassays. Its reproducible reactivity in established assay formats, such as enzyme-linked immunospot (ELISPOT) or intracellular cytokine staining, ensures the reliability and comparability of experimental results. The use of this peptide in assay validation workflows underpins robust immune monitoring, enabling high-confidence interpretation of T-cell activity in basic and applied research contexts.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis